215 related articles for article (PubMed ID: 29264954)
1. Mechanisms of right heart disease in pulmonary hypertension (2017 Grover Conference Series).
Asosingh K; Erzurum S
Pulm Circ; 2018; 8(1):2045893217753121. PubMed ID: 29264954
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
4. The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series).
Harrison A; Hatton N; Ryan JJ
Pulm Circ; 2015 Mar; 5(1):29-47. PubMed ID: 25992269
[TBL] [Abstract][Full Text] [Related]
5. miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
Shi L; Kojonazarov B; Elgheznawy A; Popp R; Dahal BK; Böhm M; Pullamsetti SS; Ghofrani HA; Gödecke A; Jungmann A; Katus HA; Müller OJ; Schermuly RT; Fisslthaler B; Seeger W; Fleming I
Cardiovasc Res; 2016 Aug; 111(3):184-93. PubMed ID: 27013635
[TBL] [Abstract][Full Text] [Related]
6. Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension.
Liu J; Yang P; Tian H; Zhen K; McCabe C; Zhao L; Zhai Z
J Transl Int Med; 2022 Jun; 10(2):125-133. PubMed ID: 35959451
[TBL] [Abstract][Full Text] [Related]
7. Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).
Tan W; Madhavan K; Hunter KS; Park D; Stenmark KR
Pulm Circ; 2014 Dec; 4(4):560-80. PubMed ID: 25610594
[TBL] [Abstract][Full Text] [Related]
8. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure.
Andersen S; Andersen A; de Man FS; Nielsen-Kudsk JE
Eur J Heart Fail; 2015 Apr; 17(4):358-66. PubMed ID: 25704592
[TBL] [Abstract][Full Text] [Related]
11. [Experts consensus on the management of the right heart function in critically ill patients].
Wang XT; Liu DW; Zhang HM; Long Y; Guan XD; Qiu HB; Yu KJ; Yan J; Zhao H; Tang YQ; Ding X; Ma XC; Du W; Kang Y; Tang B; Ai YH; He HW; Chen DC; Chen H; Chai WZ; Zhou X; Cui N; Wang H; Rui X; Hu ZJ; Li JG; Xu Y; Yang Y; Ouyan B; Lin HY; Li YM; Wan XY; Yang RL; Qin YZ; Chao YG; Xie ZY; Sun RH; He ZY; Wang DF; Huang QQ; Jiang DP; Cao XY; Yu RG; Wang X; Chen XK; Wu JF; Zhang LN; Yin MG; Liu LX; Li SW; Chen ZJ; Luo Z;
Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):962-973. PubMed ID: 29202543
[TBL] [Abstract][Full Text] [Related]
12. The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series).
Bristow MR; Quaife RA
Pulm Circ; 2015 Sep; 5(3):415-23. PubMed ID: 26401244
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension reduces energy efficiency of right, but not left, rat ventricular trabeculae.
Pham T; Nisbet L; Taberner A; Loiselle D; Han JC
J Physiol; 2018 Apr; 596(7):1153-1166. PubMed ID: 29363144
[TBL] [Abstract][Full Text] [Related]
14. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.
Antigny F; Mercier O; Humbert M; Sabourin J
Arch Cardiovasc Dis; 2020 Jan; 113(1):70-84. PubMed ID: 31924541
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology.
Badagliacca R; Poscia R; Pezzuto B; Nocioni M; Mezzapesa M; Francone M; Giannetta E; Papa S; Gambardella C; Sciomer S; Volterrani M; Fedele F; Dario Vizza C
J Heart Lung Transplant; 2015 Mar; 34(3):395-403. PubMed ID: 25499139
[TBL] [Abstract][Full Text] [Related]
16. Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle.
Stam K; Cai Z; van der Velde N; van Duin R; Lam E; van der Velden J; Hirsch A; Duncker DJ; Merkus D
J Physiol; 2019 Sep; 597(17):4465-4480. PubMed ID: 31194256
[TBL] [Abstract][Full Text] [Related]
17. The right ventricle in scleroderma (2013 Grover Conference Series).
Hassoun PM
Pulm Circ; 2015 Mar; 5(1):3-14. PubMed ID: 25992267
[TBL] [Abstract][Full Text] [Related]
18. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
19. Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?
Rasmussen JT; Thenappan T; Benditt DG; Weir EK; Pritzker MR
Pulm Circ; 2014 Dec; 4(4):552-9. PubMed ID: 25610593
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
